Evaluation of platelet inhibition by tirofiban in patients stratified according to aspirin and clopidogrel responsiveness: the 3T/2R (Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel)

J Am Coll Cardiol. 2010 Jan 19;55(3):255-6. doi: 10.1016/j.jacc.2009.08.052.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects*
  • Aspirin / therapeutic use
  • Clopidogrel
  • Cohort Studies
  • Drug Resistance*
  • Humans
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / prevention & control*
  • Patient Selection*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use
  • Tirofiban
  • Tyrosine / analogs & derivatives*
  • Tyrosine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Tyrosine
  • Clopidogrel
  • Tirofiban
  • Ticlopidine
  • Aspirin